Stride
LRN
79.62
-0.13
-0.16%
Stride
US · LRN
#2428 by market cap
Listed 1970
79.62
-0.13
-0.16%
Live - 5344 symbols - heartbeat 43s ago
· 2026-10-07 19:54
After-hours
79.62
0.00%
- Market cap
- 3.31B
- P/E (TTM)i
- 11.15
- P/Bi
- 2.03
- EPSi
- 7.14
- Div yieldi
- 0.00%
- 52W posi
- 20%
Reader sentiment
Are you bullish or bearish on LRN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.50, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +4.69% YoY
Margins
- Gross margin
- 37.75%
- Operating margin
- 17.90%
- Net margin
- 13.43%
Key ratios & quality
- Enterprise valuei
- 2.83B
- PEG ratioi
- 0.29
- Altman Z-Scorei
- 5.50
PEG uses trailing P/E against the 3-year net income growth rate (38.66%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.02B | 1.04B | 1.54B | 1.69B | 1.84B | 2.04B | 2.41B | 2.52B |
| Gross profit | 352.32M | 347.53M | 534.90M | 596.48M | 647.07M | 763.60M | 943.92M | 950.60M |
| Selling & admin expenses | 306.83M | 315.08M | 424.44M | 439.85M | 481.57M | 514.00M | 524.35M | 499.83M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 45.49M | 32.46M | 110.46M | 156.63M | 165.50M | 249.60M | 419.57M | 450.77M |
| Pretax profit | 48.36M | 33.43M | 95.31M | 147.07M | 172.55M | 267.69M | 383.22M | 441.16M |
| Tax | 10.52M | 8.54M | 24.54M | 40.09M | 45.35M | 64.48M | 93.01M | 102.77M |
| Net profit | 37.21M | 24.51M | 71.45M | 107.13M | 126.87M | 204.18M | 287.94M | 338.19M |
| Basic EPS | 1 | 1 | 2 | 3 | 3 | 5 | 7 | 8 |
| Diluted EPS | 0.91 | 0.60 | 1.71 | 2.52 | 2.97 | 4.69 | 5.95 | 7.14 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 613.38M | 653.65M | 620.88M | 631.26M | 629.87M | 636.06M |
| Gross profit | 249.29M | 238.92M | 242.12M | 259.63M | 231.57M | 217.28M |
| Selling & admin expenses | 118.50M | 122.58M | 173.14M | 112.78M | 102.49M | 111.43M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 130.79M | 116.34M | 68.98M | 146.85M | 129.08M | 105.85M |
| Pretax profit | 135.36M | 64.33M | 82.82M | 133.27M | 120.74M | 104.33M |
| Tax | 35.45M | 12.92M | 14.42M | 33.97M | 31.55M | 22.83M |
| Net profit | 99.35M | 51.32M | 68.80M | 99.48M | 88.53M | 81.39M |
| Basic EPS | 2 | 1 | 2 | 2 | 2 | 2 |
| Diluted EPS | 2.02 | 1.03 | 1.40 | 2.12 | 1.93 | 1.75 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 529.66M | 501.27M | 857.53M | 950.53M | 1.07B | 1.25B | 1.63B | 1.72B |
| Cash & ST investments | 283.12M | 212.30M | 386.08M | 389.40M | 522.73M | 692.29M | 985.27M | 958.00M |
| Inventory | 29.95M | 28.30M | 39.69M | 36.00M | 36.72M | 36.75M | 37.57M | 38.25M |
| Total assets | 819.61M | 1.07B | 1.58B | 1.64B | 1.76B | 1.92B | 2.29B | 2.44B |
| Total current liabilities | 155.59M | 273.42M | 306.24M | 302.07M | 309.14M | 244.28M | 302.88M | 288.85M |
| Short-term debt | 19.59M | 133.99M | 47.99M | 50.22M | 50.07M | 41.89M | 53.71M | 63.21M |
| Long-term debt | -- | -- | 299.27M | 411.44M | 413.04M | 414.68M | 416.32M | 418.00M |
| Total liabilities | 186,241,000.00 | 397,934,000.00 | 772,649,000.00 | 830,964,000.00 | 813,370,000.00 | 744,440,000.00 | 814,340,000.00 | 803,223,000.00 |
| Total equity | 633.37M | 675.33M | 804.65M | 812.58M | 947.30M | 1.18B | 1.48B | 1.63B |
| Retained earnings | 22.45M | 46.95M | 112.15M | 227.46M | 354.33M | 558.51M | 846.45M | 1.18B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.51B | 1.63B | 1.65B | 1.60B | 1.76B | 1.72B |
| Cash & ST investments | 723.69M | 985.27M | 715.10M | 625.71M | 805.84M | 958.00M |
| Inventory | 22.38M | 37.57M | 19.81M | 17.94M | 21.50M | 38.25M |
| Total assets | 2.21B | 2.29B | 2.33B | 2.31B | 2.45B | 2.44B |
| Total current liabilities | 269.57M | 302.88M | 243.56M | 220.13M | 283.17M | 288.85M |
| Short-term debt | 56.32M | 53.71M | 65.81M | 62.53M | 61.74M | 63.21M |
| Long-term debt | 415.91M | 416.32M | 416.75M | 417.18M | 417.58M | 418.00M |
| Total liabilities | 790,572,000.00 | 814,340,000.00 | 805,707,000.00 | 758,709,000.00 | 805,011,000.00 | 803,223,000.00 |
| Total equity | 1.42B | 1.48B | 1.53B | 1.55B | 1.64B | 1.63B |
| Retained earnings | 795.13M | 846.45M | 915.25M | 1.01B | 1.10B | 1.18B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 141.61M | 80.42M | 134.15M | 206.88M | 203.15M | 278.80M | 432.82M | 433.81M |
| Depreciation & amortization | 71.40M | 72.09M | 90.08M | 97.91M | 110.36M | 109.68M | 114.67M | 126.56M |
| Free cash flow | 93.20M | 35.42M | 81.89M | 139.26M | 136.60M | 217.21M | 372.81M | 354.97M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | 0 | 0 | -188.66M |
| Ending cash balance | 284.62M | 213.30M | 386.58M | 389.40M | 410.81M | 500.61M | 782.50M | 754.50M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 53.13M | 298.32M | -195.78M | 91.84M | 220.91M | 316.85M |
| Depreciation & amortization | 28.94M | 30.20M | 29.23M | 30.95M | 32.60M | 33.78M |
| Free cash flow | 37.32M | 283.72M | -217.48M | 75.87M | 202.36M | 294.22M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -- | -- | 0 | -100.01M |
| Ending cash balance | 531.13M | 782.50M | 518.44M | 497.10M | 614.05M | 754.50M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 6.10 | 3.75 | 9.66 | 13.25 | 14.42 | 19.23 | 21.69 | 21.74 |
| ROA %i | 4.77 | 2.59 | 5.39 | 6.65 | 7.45 | 11.09 | 13.66 | 14.30 |
| ROIC %i | 5.85 | 3.12 | 6.55 | 8.09 | 9.27 | 13.20 | 15.85 | 16.50 |
| 5-year avg ROE %i | 2.93 | 3.27 | 4.87 | 7.50 | 9.43 | 12.06 | 15.65 | 18.06 |
| EBIT margin %i | 4.48 | 3.12 | 7.19 | 9.29 | 9.85 | 13.55 | 16.37 | 17.99 |
| FCF / sales %i | 9.18 | 3.40 | 5.33 | 8.26 | 7.43 | 10.65 | 15.50 | 14.10 |
| Current ratioi | 3.40 | 1.83 | 2.80 | 3.15 | 3.45 | 5.10 | 5.39 | 5.94 |
| Quick ratioi | 3.05 | 1.64 | 2.47 | 2.67 | 3.19 | 4.77 | 5.10 | 5.62 |
| Debt / assetsi | 3.01 | 21.91 | 29.56 | 34.42 | 30.89 | 27.50 | 23.97 | 22.42 |
| LT debt / equityi | 0.80 | 14.98 | 51.99 | 63.43 | 52.12 | 41.35 | 33.53 | 29.58 |
| Interest coveragei | -- | -- | -- | -- | 21.53 | 31.38 | 37.48 | 38.46 |
| Revenue CAGR (3Y) %i | 5.19 | 5.41 | 18.75 | 18.42 | 20.86 | 9.90 | 12.56 | 11.08 |
| Net income CAGR (3Y) %i | 60.29 | 278.76 | 37.28 | 42.26 | 72.99 | 41.91 | 39.04 | 38.66 |
| FCF CAGR (3Y) %i | 16.54 | -4.37 | 9.57 | 14.32 | 56.82 | 38.43 | 38.85 | 37.48 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 23.76 | 21.69 | 23.04 | 22.26 | 20.14 | 21.74 |
| ROA %i | 14.60 | 13.66 | 14.67 | 14.57 | 13.24 | 14.30 |
| ROIC %i | 16.97 | 15.85 | 16.68 | 16.45 | 15.21 | 16.50 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 17.84 | 16.37 | 17.11 | 16.96 | 16.28 | 17.99 |
| FCF / sales %i | 10.71 | 15.50 | 12.61 | 7.12 | 13.59 | 14.10 |
| Current ratioi | 5.61 | 5.39 | 6.77 | 7.27 | 6.21 | 5.94 |
| Quick ratioi | 5.28 | 5.10 | 6.26 | 6.79 | 5.86 | 5.62 |
| Debt / assetsi | 25.44 | 23.97 | 25.20 | 24.12 | 22.37 | 22.42 |
| LT debt / equityi | 35.66 | 33.53 | 34.19 | 31.90 | 29.58 | 29.58 |
| Interest coveragei | 40.27 | 37.48 | 37.72 | 37.57 | 35.63 | 38.46 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Educational platform to deliver proprietary and third-party curriculum, software systems and100.00%
Region
United States100.00%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.